Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

SM-215 promotes hair growth by improving the environment around hair follicles.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Hormones and genes affect hair growth and male baldness.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.